Mitochondrial and cytoplasmic aspartate aminotransferase enzyme release in the calcium paradox.
The release of mitochondrial and cytoplasmic aspartate aminotransferase (AST) enzymes from the myocardium was studied in the isolated rabbit heart under conditions of the calcium paradox. Four different periods of calcium-free perfusion for 10, 15, 20, and 25 min were selected to produce different degrees of the calcium paradox and the associated myocardial damage which was indicated by impairment in the left ventricular contractile function. Calcium-free perfusion periods of less than 20 min were associated with partial recovery of ventricular function, while periods of 20 min or greater were associated with little or no recovery of contraction after reperfusion with calcium. Mitochondrial (ASTm) and cytoplasmic (ASTc) aspartate aminotransferase were released from the heart beginning within 1 min of reintroduction of Ca2+. The cumulative amount of ASTm release was about one-tenth the amount of ASTc release. The cumulative amount of ASTm and ASTc released were significantly (p less than 0.05) related to the duration of calcium-free perfusion. The time to 90% of maximum AST release was slightly longer for ASTm compared with ASTc (6.8 +/- 0.6 vs. 5.7 +/- 0.5 min, 0.10 greater than p greater than 0.05). ASTc but not ASTm correlated significantly (p less than 0.05) with total protein release from the myocardium, while ASTm was not as consistently related to protein loss. The cumulative amount of ASTm and ASTc were inversely related to the extent of recovery of left ventricular contractile function. Disparities did occur as the longest duration of the calcium-free period, which did not produce any further damage to left ventricular function, was nonetheless associated with more enzyme release from the myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)
D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism*; D002118:Calcium / Q000494:pharmacology / Q000502:physiology*; D003593:Cytoplasm / Q000201:enzymology*; D005260:Female; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006352:Heart Ventricles; D066298:In Vitro Techniques; D008929:Mitochondria, Heart / Q000201:enzymology*; D009200:Myocardial Contraction; D009206:Myocardium / Q000201:enzymology*; D010477:Perfusion; D011817:Rabbits
D001219:Aspartate Aminotransferases; D002118:Calcium